Last updated: June 4, 2026
LO SIMPESSE suppliers: Who manufactures the branded drug and supplies the ingredients?
No information is available in the provided prompt to identify LO SIMPESSE drug-product suppliers, contract manufacturing organizations (CMOs), ingredient (API) suppliers, or distribution partners with verifiable names, geographies, and ownership/contract status.
Which companies supply LO SIMPESSE drug product (manufacturer vs CMO)?
No supplier entities are provided for LO SIMPESSE, so drug-product manufacturing supply cannot be mapped.
How to tell the true supplier from labeling and FDA records?
No LO SIMPESSE label or FDA listing data is provided to extract:
- applicant (NDA/ANDA/505(b)(2) holder)
- manufacturing locations (drug product)
- testing sites
- registered establishments
Who supplies LO SIMPESSE API (active ingredient manufacturer)?
No active ingredient identity, API dossier, or supplier list is provided, so API supply cannot be determined.
What API sources are typical for this product class?
No formulation class, API salt form, or dossier mapping is provided for LO SIMPESSE.
What is the Orange Book status of LO SIMPESSE and what does it imply for sourcing?
No FDA Orange Book listing or product identifiers (NDA/ANDA number) are provided for LO SIMPESSE, so:
- listed manufacturers
- patent linkages that can indicate manufacturing sites and applicants
- exclusivity holders
cannot be stated.
What contract manufacturing footprint supports LO SIMPESSE distribution?
No distribution network, repackager, wholesaler, or labeler is provided for LO SIMPESSE, so the supply chain footprint cannot be identified.
How does LO SIMPESSE sourcing change across strengths, dosage forms, and packaging?
No strengths, dosage forms, NDCs, or package configurations are provided, so sourcing differences by presentation cannot be compared.
Which suppliers are likely challenged by generics for LO SIMPESSE supply risk?
No generic entry risk scenario can be tied to LO SIMPESSE without:
- FDA approvals
- Paragraph IV filings
- settlement agreements
- approved ANDA/505(b)(2) product details
Key Takeaways
- LO SIMPESSE supplier mapping (drug product, API, and distribution) cannot be produced from the information provided.
- No verifiable manufacturer, CMO, API supplier, or FDA-listed establishments can be listed for LO SIMPESSE based on the prompt.
FAQs
- Who is the labeler for LO SIMPESSE?
- Which CMOs manufacture LO SIMPESSE drug product?
- Who supplies the LO SIMPESSE API?
- What NDCs correspond to LO SIMPESSE and which sites manufacture each?
- Does LO SIMPESSE have an Orange Book listing that names manufacturers?
References
No sources were provided or can be cited from the prompt.
